Nicole Basset-Seguin Selected Research

Nicole Basset-Seguin Research Topics

Disease

22	Melanoma (Melanoma, Malignant) 01/2022 - 08/2005
16	Basal Cell Carcinoma (Rodent Ulcer) 05/2022 - 07/2006
8	Neoplasms (Cancer) 05/2021 - 04/2010
7	Squamous Cell Carcinoma (Epidermoid Carcinoma) 10/2021 - 09/2011
6	Skin Neoplasms (Skin Cancer) 03/2019 - 08/2005
6	Actinic Keratosis 05/2017 - 01/2007
3	Neoplasm Metastasis (Metastasis) 01/2018 - 02/2014
3	Bowen's Disease (Disease, Bowen) 06/2016 - 01/2007
2	Pain (Aches) 12/2018 - 10/2017
2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2018 - 11/2017
2	Disease Progression 01/2017 - 08/2014
1	Dermatofibrosarcoma 05/2021
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021
1	Squamous Cell Carcinoma of Head and Neck 10/2020
1	Basal Cell Nevus Syndrome (Gorlin Syndrome) 01/2020
1	Carcinoma (Carcinomatosis) 06/2019
1	Keratoacanthoma 06/2019
1	Metabolic Bone Diseases (Osteopenia) 12/2018
1	Osteoporosis 12/2018
1	Type 2 Diabetes Mellitus (MODY) 01/2018
1	Insulin Resistance 01/2018
1	Hyperplasia 12/2017
1	Cushing Syndrome 12/2017
1	Pituitary Neoplasms (Pituitary Adenoma) 12/2017
1	Dropped Head Syndrome 10/2017
1	Fatigue 10/2017
1	Muscle Hypotonia (Hypotonia) 10/2017
1	Muscular Diseases (Myopathy) 10/2017
1	Confusion (Bewilderment) 11/2016
1	Skin Diseases (Skin Disease) 07/2015
1	Albinism 11/2011
1	Pigmented Nevus (Melanocytic Nevus) 10/2010
1	Neoplasm Micrometastasis 10/2009
1	Cicatrix (Scar) 08/2008

Drug/Important Bio-Agent (IBA)

9	HhAntag691IBA 01/2022 - 08/2014
6	1-phenyl-3,3-dimethyltriazene (PDT)IBA 05/2017 - 01/2007
4	Biomarkers (Surrogate Marker)IBA 01/2016 - 10/2009
3	sonidegibIBA 05/2022 - 10/2016
3	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2022 - 10/2017
3	Pharmaceutical PreparationsIBA 01/2022 - 03/2015
3	pembrolizumabIBA 10/2021 - 01/2020
3	Immune Checkpoint InhibitorsIBA 12/2017 - 10/2017
3	VemurafenibIBA 10/2017 - 02/2014
3	Monophenol Monooxygenase (Tyrosinase)IBA 11/2011 - 03/2007
2	Messenger RNA (mRNA)IBA 06/2018 - 01/2012
2	Interleukin-2 (IL2)IBA 01/2018 - 01/2018
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2016 - 10/2009
2	Basigin (Extracellular Matrix Metalloproteinase Inducer (EMMPRIN))IBA 01/2016 - 10/2009
2	Biological ProductsIBA 10/2010 - 03/2007
2	Type 1 Melanocortin ReceptorIBA 07/2006 - 08/2005
1	Tyrosine Kinase InhibitorsIBA 05/2021
1	Imatinib Mesylate (Gleevec)FDA Link 05/2021
1	cemiplimabIBA 01/2021
1	LigandsIBA 10/2020
1	Acitretin FDA Link 06/2019
1	DNA (Deoxyribonucleic Acid)IBA 03/2019
1	Sunscreening Agents (Sunscreens)IBA 03/2019
1	Cholecalciferol (Vitamin D3)FDA Link 12/2018
1	Zoledronic Acid (Zometa)FDA Link 12/2018
1	CalciumIBA 12/2018
1	AntibodiesIBA 01/2018
1	Blood Glucose (Blood Sugar)IBA 01/2018
1	C-Reactive ProteinIBA 01/2018
1	Adrenocorticotropic Hormone (ACTH)FDA Link 12/2017
1	Hydrocortisone (Cortisol)FDA LinkGeneric 12/2017
1	NivolumabIBA 11/2017
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 10/2017
1	cobimetinibIBA 10/2017
1	parkin proteinIBA 03/2016
1	Metalloproteases (Metalloproteinases)IBA 01/2016
1	CreatinineIBA 01/2016
1	IpilimumabIBA 01/2015
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2015
1	ParaffinIBA 01/2012
1	Cetuximab (Erbitux)FDA Link 09/2011
1	ErbB Receptors (EGF Receptor)IBA 09/2011
1	Monoclonal AntibodiesIBA 09/2011
1	Protein PrecursorsIBA 04/2010
1	EnzymesIBA 04/2010
1	Proprotein Convertases (Pro-Opiomelanocortin Converting Enzyme)IBA 04/2010
1	Genetic Markers (Genetic Marker)IBA 12/2009
1	AntigensIBA 10/2009
1	Differentiation AntigensIBA 10/2009
1	Complement System Proteins (Complement)IBA 09/2008
1	methyl 5-aminolevulinateIBA 09/2008
1	leucylleucine (Leu-Leu)IBA 09/2008
1	phenylalanylleucineIBA 09/2008
1	Sulfides (Thioethers)IBA 08/2008
1	Chemokine ReceptorsIBA 04/2007
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 04/2007

Therapy/Procedure

12	Therapeutics 01/2022 - 01/2007
4	Immunotherapy 01/2022 - 01/2018
4	Photochemotherapy (Photodynamic Therapy) 06/2016 - 01/2007
3	Drug Therapy (Chemotherapy) 10/2020 - 09/2011
2	Neoadjuvant Therapy 05/2021 - 05/2021
2	Duration of Therapy 01/2018 - 11/2016
1	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2018
1	Rejuvenation 07/2015
1	Radiotherapy 03/2015
1	Cryotherapy (Therapy, Cold) 09/2008